您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Cong Chen1, Guanjia Qiao2, Dantong Tang1
1Department of Neurology, First Hospital of China Medical University, Shenyang, Liaoning Province, China; Key Laboratory of Neurological Disease Big Data of Liaoning Province, Shenyang, China; Shenyang Clinical Medical Research Center for Difficult and Serious Diseases of the Nervous System, China.
针对殖民地刺激因子受体1 (CSF1R) 抑制剂的微细胞再生策略显示出对中枢神经系统 (CNS) 疾病的治疗潜力. 单细胞测序揭示了微质异质性和新疗法的自我更新能力.
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: